Evidence map›Paper›PMID 35479945›Full record

ArticleFrontiers in medicine2022

Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria.

Qingya Cui, Haiping Dai, Depei Wu, Jun He, Yang Xu, Xiaowen Tang, Jie Xu

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Qingya CuiNational Clinical Research Center for Hematologic Diseases, Hematology Department, Jiangsu Institute of Hematology, The First Hospital Affiliated to Soochow University, Suzhou, China.
Haiping DaiNational Clinical Research Center for Hematologic Diseases, Hematology Department, Jiangsu Institute of Hematology, The First Hospital Affiliated to Soochow University, Suzhou, China.
Depei WuNational Clinical Research Center for Hematologic Diseases, Hematology Department, Jiangsu Institute of Hematology, The First Hospital Affiliated to Soochow University, Suzhou, China.
Jun HeNational Clinical Research Center for Hematologic Diseases, Hematology Department, Jiangsu Institute of Hematology, The First Hospital Affiliated to Soochow University, Suzhou, China.
Yang XuDinfectome Inc., Nanjing, China.
Xiaowen TangNational Clinical Research Center for Hematologic Diseases, Hematology Department, Jiangsu Institute of Hematology, The First Hospital Affiliated to Soochow University, Suzhou, China.
Jie XuCenter of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary mucormycosis (PM) is a rare and life-threatening fungal infection. Here, we report a case of an acute T lymphoblastic leukemia patient with mixed infections of lethal invasive Mucormycosis and multi-drug resistant (MDR) bacteria. After receiving anti-infection drugs to control the patient's fever, he was treated with induction chemotherapy. However, the malignant hematological disease was poorly controlled by the chemotherapy and the patient developed more symptoms of infection. Although the results of multiple β-D-Glucan (G) and Galactomannan (GM) tests remained negative, several pathogens were detected using metagenomic next-generation sequencing (mNGS). In particular, mNGS identified

Indexed as

acute T lymphoblastic leukemiametagenomic next-generation sequencingMucor infectionmulti-drug resistant bacteriapulmonary mucormycosis

Identifiers

PMID35479945
PMCPMC9037592
OpenAlexW4223470233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.